Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

This Research Topic is part of the article collection series -<a href=" Plant Genotyping: From Traditional Markers to Modern ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. Not all ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.

There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...

No, no, no, that’s not how I want to start! I want to start in a major key. Please, take 2 minutes, 52 seconds on YouTube to watch Kelly Boesch’s beautiful and mesmerizing AI-produced ...

Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism.

Gene editing has the potential to cure thousands of people suffering from devastating rare diseases. But the Nobel Prize-winning technology faces a basic math problem: It’s not profitable to spend ...

Researchers at the University of Hawaiʻi at Mānoa have developed new mouse models to study a key male fertility gene, ...